Viral Hepatitis A, B & C: Surveillance, Prevention & Control
Last Updated on January 25, 2020 by HepFree NYC
Related Articles
-
Report Medicaid Managed Care Pharmacy & Medication ‘Issues’ to NYS DOH Pharmacy Program
Report Medicaid Managed Care Pharmacy & Medication ‘Issues’ to NYS DOH Pharmacy Program by describing the issue in detail in an email to: PPNO@Health.state.ny.US. Medical Providers, Patient Navigators, Case Managers, Care Managers, Advocates, Pharmacists, Patients...
-
Hep C Patients: Share Your Story for a Documentary Film
An Academy Award winning director is seeking Hep C patients for a web documentary film about Hep C and the challenges related to living with the disease.
-
Comment | NYC Health Code Amendment – Reporting Negative Hep B Test Results (Due 10/25/17)
The NYC Health Department is proposing that the Board amend Health Code §13.03(b)(3)(A) to require laboratories to report all hepatitis B virus (Hep B) DNA test results, including negative results - please comment!
-
Emily Winkelstein, MSW
Advisory Board NYC Hep C Task Force Emily Winkelstein, MSW, Cross Systems Program Specialist, NYC Health Department, Bureau of Alcohol & Drug Use Prevention, Care & Treatment. (ewinkelstein@health.nyc.gov) is currently working in the NYC Health Department Alcohol and Drug...
-
Presidential Proclamation | World Hepatitis Day 2014
Presidential Proclamation | World Hepatitis Day 2014 See original post here. – – – – – – – BY THE PRESIDENT OF THE UNITED STATES OF AMERICA A PROCLAMATION Around the world, one in twelve people are living with viral hepatitis. In the Unit...
-
NYS Health Department Defines HCV Experienced Provider
As New York State enters this era of successful HCV treatment, the NYSDOH AIDS Institute has developed criteria for defining those providers qualified to manage and treat patients with HCV infection.
-
Leaders Call For End To Hep C Treatment Access Crisis
A coalition of leading hepatitis C advocacy organizations and medical experts today called on Health and Human Services Secretary Sylvia Mathews Burwell to take leadership in eliminating harmful and discriminatory barriers to hepatitis C treatment access.
-
Hep C Medication Prior Authorization Requirements Reduced in NYS Fee for Service Medicaid
NYS Medicaid FFS removed prior authorizations for first time direct acting antivirals (DAAs) treatment of Hep C infection and for re-treatment within one year for any reason.
